223 related articles for article (PubMed ID: 16704874)
1. Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants.
Devreese KM
Thromb Res; 2007; 119(3):369-76. PubMed ID: 16704874
[TBL] [Abstract][Full Text] [Related]
2. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
Moore GW; Savidge GF
Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
Hong SK; Hwang SM; Kim JE; Kim HK
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767
[TBL] [Abstract][Full Text] [Related]
4. Further evidence of false negative screening for lupus anticoagulants.
Moore GW; Henley A; Greenwood CK; Rangarajan S
Thromb Res; 2008; 121(4):477-84. PubMed ID: 17602725
[TBL] [Abstract][Full Text] [Related]
5. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
Ieko M; Naito S; Yoshida M
Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
[TBL] [Abstract][Full Text] [Related]
6. The Lupus Ratio test--an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Fifth International Survey of Lupus Anticoagulants--ISLA 5.
Jacobsen EM; Barna-Cler L; Taylor JM; Triplett DA; Wisløff F
Thromb Haemost; 2000 May; 83(5):704-8. PubMed ID: 10823266
[TBL] [Abstract][Full Text] [Related]
7. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
Devreese KM
Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
[TBL] [Abstract][Full Text] [Related]
9. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
[TBL] [Abstract][Full Text] [Related]
10. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
Brandt JT; Triplett DA; Musgrave K; Orr C
Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
[TBL] [Abstract][Full Text] [Related]
11. A lupus anticoagulant neutralization procedure using the patient's own platelets.
Carroll P; Ray M; Just S; Hawson G
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):523-7. PubMed ID: 7841308
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a standardized procedure with current laboratory practices for the detection of lupus anticoagulant in France. Working Group on Hemostasis of the Société Française de Biologie Clinique.
Thromb Haemost; 1993 Nov; 70(5):781-6. PubMed ID: 8128435
[TBL] [Abstract][Full Text] [Related]
13. Two different incubation times for the activated partial thromboplastin time (APTT): a new criterion for diagnosis of lupus anticoagulant.
Robert A
Thromb Haemost; 1994 Feb; 71(2):220-4. PubMed ID: 8191402
[TBL] [Abstract][Full Text] [Related]
14. A "percent correction" formula for evaluation of mixing studies.
Chang SH; Tillema V; Scherr D
Am J Clin Pathol; 2002 Jan; 117(1):62-73. PubMed ID: 11789732
[TBL] [Abstract][Full Text] [Related]
15. Differences in lupus anticoagulant final conclusion through clotting time or Rosner index for mixing test interpretation.
Depreter B; Devreese KM
Clin Chem Lab Med; 2016 Sep; 54(9):1511-6. PubMed ID: 26894579
[TBL] [Abstract][Full Text] [Related]
16. [Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time].
Guermazi S; Gorgi Y; Ayed K; Dellagi K
Pathol Biol (Paris); 1997 Jan; 45(1):28-33. PubMed ID: 9097843
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
[TBL] [Abstract][Full Text] [Related]
18. Screening for lupus anticoagulant: improving the performance of the lupus-sensitive PTT-LA.
Luginbühl R; Barizzi G; Sulzer I; Lämmle B; Alberio L
Int J Lab Hematol; 2011 Apr; 33(2):168-75. PubMed ID: 20860735
[TBL] [Abstract][Full Text] [Related]
19. The laboratory diagnosis of lupus anticoagulants.
Lazarchick J; Kizer J
Arch Pathol Lab Med; 1989 Feb; 113(2):177-80. PubMed ID: 2492798
[TBL] [Abstract][Full Text] [Related]
20. New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests.
Martinuzzo ME; Cerrato GS; Varela ML; Adamczuk YP; Forastiero RR
Int J Lab Hematol; 2012 Apr; 34(2):208-13. PubMed ID: 22032515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
